Worboys Philip D

SVP, Research & Transl Science at TBPH

Sold, on record
$743k
Dollars the filings state
Form 4 sales
4
Latest Mar 9, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TBPHTheravance Biopharma, Inc.SVP, Research & Transl Science

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale TBPHPlan not stated
    Sep 12, 2018 2018

    Sold 6,393 shares at $28.50 ($182k)

    Worboys Philip D, SVP, Translational Science

    Sold 3.7% of holdings ($4.9M position)166,753 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale TBPHPlan not stated
    Aug 20, 2020 +708 days

    Sold 17,103 shares at $18.00 ($308k)

    Worboys Philip D, SVP, Research & Transl Science

    Sold 4.9% of holdings ($6.3M position)333,252 shares leftFiling

  3. 3 Form 4 sale TBPHPlan not stated
    Dec 3, 2020 +105 days

    Sold 4,246 shares at $18.00 ($76k)

    Worboys Philip D, SVP, Research & Transl Science

    Sold 1.3% of holdings ($5.8M position)319,395 shares leftFiling

  4. 4 Form 4 sale TBPHPlan not stated
    Mar 9, 2021 +96 days

    Sold 8,829 shares at $20.00 ($177k)

    Worboys Philip D, SVP, Research & Transl Science

    Sold 2.5% of holdings ($7.1M position)343,679 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Worboys Philip D
Source
Mar 9, 2021Mar 11, 2021TBPHSVP, Research & Transl ScienceForm 4 sale8,829$177k2.5%Plan not statedSEC
Dec 3, 2020Dec 7, 2020TBPHSVP, Research & Transl ScienceForm 4 sale4,246$76k1.3%Plan not statedSEC
Aug 20, 2020Aug 24, 2020TBPHSVP, Research & Transl ScienceForm 4 sale17,103$308k4.9%Plan not statedSEC
Sep 12, 2018Sep 14, 2018TBPHSVP, Translational ScienceForm 4 sale6,393$182k3.7%Plan not statedSEC